Searched for
SCHERING PLOUGH
- Merck to take buyout route to grow hereThe world’s second-biggest drugmaker, Merck & Co, is looking at acquisitions and alliances with local firms to scale up its business in Ind...15 Nov, 2010, 01.28 AM IST
- HC rejects Fulford plea against United Biotech, Oscar RemediesWhen a trademark is derived from the common generic name, no single proprietor can claim absolute monopoly in such name or trade mark, rule...11 Oct, 2010, 06.23 AM IST
- Merck plans to shift India head office to MumbaiUS-based drugmaker Merck plans to relocate headquarter of its India office to Mumbai, making it the third major pharma company to shift key...10 May, 2010, 01.30 AM IST
- Merck Q1 sales rise but profit fall on chargesDrugmaker Merck & Co. says double-digit sales growth for a half-dozen of its top medicines fueled a 7 percent jump in first-quarter sales.04 May, 2010, 05.20 PM IST
- Pfizer, Merck to cut 1,700 jobs following mergersCombined, Pfizer and Wyeth plan to cut about 20,000 jobs, or 15 percent of their combined staff in the future. Top 10 Paymasters | Intervie...12 Jan, 2010, 12.52 AM IST
- US court to hear Glenmark's patent dispute on Aug 19Glenmark Pharmaceuticals’ patent challenge against Schering Plough’s cholesterol-lowering drug Zetia will come up for hearing in the US dis...07 Aug, 2009, 12.59 AM IST
- Glenmark gets first nod for Zetia genericGlenmark Pharmaceuticals has got tentative approval from the USFDA for the generic version of Schering Plough and MSP Singapore Company LLC...27 Apr, 2009, 03.44 PM IST
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.10 Mar, 2009, 10.27 AM IST
- Merck buys Schering-Plough for $41 bn to access new drugsUS-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.10 Mar, 2009, 03.10 AM IST
- Pharmaceutical giants Merck, Schering-Plough announce mergerUS pharmaceutical giants Merck and Schering-Plough announced their merger early on Monday in a stock-and-cash transaction valued 41.1 billi...09 Mar, 2009, 04.21 PM IST
- Lupin gains 4% over drug patent settlementDrug maker Lupin rose over 4 per cent after the firm said it had settled a patent litigation with US-based Schering-Plough Corp relating to...18 Dec, 2008, 11.07 AM IST
- Lupin declares litigation settlement with Schering-PloughLupin Ltd has settled all ongoing Hatch-Waxman litigation relating to desloratadine tablets, the generic version of Schering-Plough's Clari...17 Dec, 2008, 05.27 PM IST
- FDA rejects Schering drug to reverse anesthesiaGovernment regulators dealt a major setback to Schering-Plough Corp, rejecting a highly anticipated drug designed to help patients recover ...02 Aug, 2008, 03.05 AM IST
- Cancer fears may spark decline in Vytorin salesSales of Merck & Co and Schering-Plough Corp’s Vytorin, falling after data earlier this year questioned its effectiveness against a cheaper...23 Jul, 2008, 01.08 AM IST
- Global pharma cos explore contract research in IndiaA new chapter is being added to the Indian pharma story. Leading global pharma and biotechnology firms, such as Schering-Plough, Bristol-My...21 Oct, 2006, 03.05 AM IST
- Schering-Plough, Sanofi set sights on Bristol-MyersBristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...18 Sep, 2006, 12.46 AM IST
- Goldman buys 7% in Fulford India for Rs 13 crGoldman Sachs’ private equity fund has bought 7% in Fulford India, an affiliate of the US-based pharma firm, Schering-Plough, for Rs 13 cro...10 Aug, 2006, 12.10 AM IST
Load More- Merck to take buyout route to grow here
